论文信息 - Safety, pharmacodynamics, and exposure-response modeling results from a first in human phase 1 study of nedosiran in primary hyperoxaluria. - 字舞流文

Safety, pharmacodynamics, and exposure-response modeling results from a first in human phase 1 study of nedosiran in primary hyperoxaluria.

B. Hoppe | J. Groothoff | K. Barrios | C. Langman | M. Coenen | M. Baum | P. Cochat | A. Koch | A. Amrite | D. McDougall | G. Lipkin | G. Schalk | Sander F. Garrelfs | Gesa Schalk